Affiliation: Northwestern University

Dr. Dmello has an extensive background in cancer biology and molecular biology fields, with specific training and expertise in cell signaling and oncogenesis. She has been able to work in diverse fields and get expertise on a wide range of research questions and techniques. Her PhD thesis work was focused on understanding the role of intermediate filament protein vimentin, in the development and progression of cancer.  She did a brief post-doctoral work on identification of interactors of Plasmodium falciparum protein P2 on the surface of malaria infected erythrocytes. Her current work in Dr. Sonabend’s laboratory focuses on identification of predictive markers for response to PTX and identification of kinases implicated in resistance to T-cell mediated immune response and immunotherapy for glioblastoma (GBM) using large-scale CRISPR screens.